Cite

HARVARD Citation

    George, T. et al. (2021). Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma. Oncologist. pp. 825-e1674. [Online]. 
  
Back to record